The Impact of the COVID-19 Pandemic on Aflibercept and Ranibizumab Anti-VEGF Injections

Related

• 

  New Data and Insights from Several DRCR.net Protocols

  Lee Jampol, MD

  Updates from the Field

  2017

• 

  New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases

  Alay S. Banker, MD

  Annual Meeting Talks

  2018

• 

  Expert Panel:PDS

  Robert A. Mittra, MD, FASRS

  Dante Joseph Pieramici, MD

  Aleksandra V. Rachitskaya, MD, FASRS

  Margaret A. Chang, MD, MS

  Carl C. Awh, MD, FASRS

  Annual Meeting Talks

  2024